A partnership of patients, scientists and clinicians

Type 1 Diabetes (T1D) is an autoimmune condition where the body's immune system attacks and destroys insulin-producing beta cells in the pancreas. Without insulin, people with T1D cannot regulate blood glucose levels effectively, leading to serious health complications.

T1D affects an estimated 400,000 people in the UK alone, and tens of millions worldwide. Current treatment relies on insulin replacement through injections or pumps, but patients often face significant challenges including hypoglycaemia, long-term complications, and burdensome daily management.

Our centre brings together experts from across Oxford and patients and their families to drive collaborative, cross-disciplinary research.